Ho Ming Cheng

BACKGROUND: Whether glycemic control influences the risk of colonic adenoma and colorectal cancer (CRC) development is unknown…

BACKGROUND: Epidemiological data on the use of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and hepatocellular carcinoma (HCC) are limited. We aimed to investigate the association of SGLT-2i use with HCC and hepatic decompensation in patients with diabetes mellitus (DM)…